USANA Health Sciences Inc
SWB:USJ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
USANA Health Sciences Inc
SWB:USJ
|
US |
|
Mueller Water Products Inc
NYSE:MWA
|
US |
|
Arvinas Inc
NASDAQ:ARVN
|
US |
|
Montem Resources Ltd
ASX:MR1
|
AU |
|
M
|
M2I Corporation
KOSDAQ:347890
|
KR |
|
Pou Sheng International (Holdings) Ltd
HKEX:3813
|
HK |
|
L
|
Largo Inc
NASDAQ:LGO
|
CA |
|
Nan Ya Plastics Corp
TWSE:1303
|
TW |
|
N
|
Noctiluca SA
WSE:NCL
|
PL |
|
Anheuser Busch Inbev SA
NYSE:BUD
|
BE |
|
GL Sciences Inc
TSE:7705
|
JP |
|
Vodafone Group PLC
LSE:VOD
|
UK |
Wall Street
Price Targets
USJ Price Targets Summary
USANA Health Sciences Inc
According to Wall Street analysts, the average 1-year price target for
USJ
is 33.35 EUR
with a low forecast of 33.03 EUR and a high forecast of 34.33 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is USJ's stock price target?
Price Target
33.35
EUR
According to Wall Street analysts, the average 1-year price target for
USJ
is 33.35 EUR
with a low forecast of 33.03 EUR and a high forecast of 34.33 EUR.
What is USANA Health Sciences Inc's Revenue forecast?
Projected CAGR
5%
For the last 14 years the
compound annual growth rate for
USANA Health Sciences Inc's revenue is
3%.
The projected
CAGR
for the next 2 years is
5%.
What is USANA Health Sciences Inc's Operating Income forecast?
Projected CAGR
22%
For the last 14 years the
compound annual growth rate for
USANA Health Sciences Inc's operating income is
-3%.
The projected
CAGR
for the next 2 years is
22%.
What is USANA Health Sciences Inc's Net Income forecast?
Projected CAGR
119%
For the last 14 years the
compound annual growth rate for
USANA Health Sciences Inc's net income is
-6%.
The projected
CAGR
for the next 2 years is
119%.
